Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Claus-Michael Lehr:

Diverse Applications of Nanomedicine. Pelaz B et al. ACS Nano. (2017)

Co-culture of human alveolar epithelial (hAELVi) and macrophage (THP-1) cell lines. Kletting S et al. ALTEX. (2018)

Barriers and motivations for non-invasive drug delivery. Loretz B et al. Eur J Pharm Biopharm. (2017)

Search results

Items: 1 to 20 of 216

1.

Advanced in vitro lung-on-chip platforms for inhalation assays: From prospect to pipeline.

Artzy-Schnirman A, Hobi N, Schneider-Daum N, Guenat OT, Lehr CM, Sznitman J.

Eur J Pharm Biopharm. 2019 Sep 6. pii: S0939-6411(19)30785-4. doi: 10.1016/j.ejpb.2019.09.006. [Epub ahead of print] Review.

PMID:
31499161
2.

Challenges and Strategies in Drug Delivery Systems for Treatment of Pulmonary Infections.

Ho DK, Nichols BLB, Edgar KJ, Murgia X, Loretz B, Lehr CM.

Eur J Pharm Biopharm. 2019 Sep 4. pii: S0939-6411(19)30620-4. doi: 10.1016/j.ejpb.2019.09.002. [Epub ahead of print] Review.

PMID:
31493510
3.

Macro- and Microrheological Properties of Mucus Surrogates in Comparison to Native Intestinal and Pulmonary Mucus.

Huck BC, Hartwig O, Biehl A, Schwarzkopf K, Wagner C, Loretz B, Murgia X, Lehr CM.

Biomacromolecules. 2019 Sep 9;20(9):3504-3512. doi: 10.1021/acs.biomac.9b00780. Epub 2019 Aug 28.

PMID:
31419118
4.

Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration.

Thanki K, van Eetvelde D, Geyer A, Fraire J, Hendrix R, Van Eygen H, Putteman E, Sami H, de Souza Carvalho-Wodarz C, Franzyk H, Nielsen HM, Braeckmans K, Lehr CM, Ogris M, Foged C.

J Control Release. 2019 Sep 28;310:82-93. doi: 10.1016/j.jconrel.2019.08.004. Epub 2019 Aug 6.

PMID:
31398360
5.

OCTN2-Mediated Acetyl-l-Carnitine Transport in Human Pulmonary Epithelial Cells In Vitro.

Salomon JJ, Gausterer JC, Selo MA, Hosoya KI, Huwer H, Schneider-Daum N, Lehr CM, Ehrhardt C.

Pharmaceutics. 2019 Aug 7;11(8). pii: E396. doi: 10.3390/pharmaceutics11080396.

6.

Preferential uptake of chitosan-coated PLGA nanoparticles by primary human antigen presenting cells.

Durán V, Yasar H, Becker J, Thiyagarajan D, Loretz B, Kalinke U, Lehr CM.

Nanomedicine. 2019 Jul 31;21:102073. doi: 10.1016/j.nano.2019.102073. [Epub ahead of print]

7.

Bioinspired Liposomes for Oral Delivery of Colistin to Combat Intracellular Infections by Salmonella enterica.

Menina S, Eisenbeis J, Kamal MAM, Koch M, Bischoff M, Gordon S, Loretz B, Lehr CM.

Adv Healthc Mater. 2019 Sep;8(17):e1900564. doi: 10.1002/adhm.201900564. Epub 2019 Jul 22.

PMID:
31328434
8.

Nanoparticle Targeting to Scalp Hair Follicles: New Perspectives for a Topical Therapy for Alopecia Areata.

Christmann R, Thomas C, Jager N, Raber AS, Loretz B, Schaefer UF, Tschernig T, Vogt T, Lehr CM.

J Invest Dermatol. 2019 Jul 2. pii: S0022-202X(19)31847-0. doi: 10.1016/j.jid.2019.05.028. [Epub ahead of print] No abstract available.

PMID:
31276676
9.

Triple co-culture of human alveolar epithelium, endothelium and macrophages for studying the interaction of nanocarriers with the air-blood barrier.

Costa A, de Souza Carvalho-Wodarz C, Seabra V, Sarmento B, Lehr CM.

Acta Biomater. 2019 Jun;91:235-247. doi: 10.1016/j.actbio.2019.04.037. Epub 2019 Apr 18.

PMID:
31004840
10.

Starch-Chitosan Polyplexes: A Versatile Carrier System for Anti-Infectives and Gene Delivery.

Yasar H, Ho DK, De Rossi C, Herrmann J, Gordon S, Loretz B, Lehr CM.

Polymers (Basel). 2018 Mar 1;10(3). pii: E252. doi: 10.3390/polym10030252.

11.

Preparation, characterisation and in vitro antibacterial property of ciprofloxacin-loaded nanostructured lipid carrier for treatment of Bacillus subtilis infection.

Nnamani P, Ugwu A, Ibezim E, Onoja S, Odo A, Windbergs M, Rossi C, Lehr CM, Attama A.

J Microencapsul. 2019 Jan;36(1):32-42. doi: 10.1080/02652048.2019.1582724. Epub 2019 Mar 4.

PMID:
30758259
12.

Vibrational spectroscopic imaging and live cell video microscopy for studying differentiation of primary human alveolar epithelial cells.

Vukosavljevic B, Hittinger M, Hachmeister H, Pilger C, Murgia X, Gepp MM, Gentile L, Huwer H, Schneider-Daum N, Huser T, Lehr CM, Windbergs M.

J Biophotonics. 2019 Jun;12(6):e201800052. doi: 10.1002/jbio.201800052. Epub 2019 Feb 20.

PMID:
30597770
13.

Aspherical and Spherical InvA497-Functionalized Nanocarriers for Intracellular Delivery of Anti-Infective Agents.

Castoldi A, Empting M, De Rossi C, Mayr K, Dersch P, Hartmann R, Müller R, Gordon S, Lehr CM.

Pharm Res. 2018 Dec 5;36(1):22. doi: 10.1007/s11095-018-2521-3.

14.

Chemically modified hCFTR mRNAs recuperate lung function in a mouse model of cystic fibrosis.

Haque AKMA, Dewerth A, Antony JS, Riethmüller J, Schweizer GR, Weinmann P, Latifi N, Yasar H, Pedemonte N, Sondo E, Weidensee B, Ralhan A, Laval J, Schlegel P, Seitz C, Loretz B, Lehr CM, Handgretinger R, Kormann MSD.

Sci Rep. 2018 Nov 13;8(1):16776. doi: 10.1038/s41598-018-34960-0.

15.

Can lifecycle management safeguard innovation in the pharmaceutical industry?

Hering S, Loretz B, Friedli T, Lehr CM, Stieneker F.

Drug Discov Today. 2018 Dec;23(12):1962-1973. doi: 10.1016/j.drudis.2018.10.008. Epub 2018 Oct 17. Review.

PMID:
30342247
16.

Medium throughput breathing human primary cell alveolus-on-chip model.

Stucki JD, Hobi N, Galimov A, Stucki AO, Schneider-Daum N, Lehr CM, Huwer H, Frick M, Funke-Chambour M, Geiser T, Guenat OT.

Sci Rep. 2018 Sep 25;8(1):14359. doi: 10.1038/s41598-018-32523-x.

17.

Kinetics of mRNA delivery and protein translation in dendritic cells using lipid-coated PLGA nanoparticles.

Yasar H, Biehl A, De Rossi C, Koch M, Murgia X, Loretz B, Lehr CM.

J Nanobiotechnology. 2018 Sep 19;16(1):72. doi: 10.1186/s12951-018-0401-y.

18.

Extracellular vesicles protect glucuronidase model enzymes during freeze-drying.

Frank J, Richter M, de Rossi C, Lehr CM, Fuhrmann K, Fuhrmann G.

Sci Rep. 2018 Aug 17;8(1):12377. doi: 10.1038/s41598-018-30786-y.

19.

Farnesylated Glycol Chitosan as a Platform for Drug Delivery: Synthesis, Characterization, and Investigation of Mucus-Particle Interactions.

Ho DK, Frisch S, Biehl A, Terriac E, De Rossi C, Schwarzkopf K, Lautenschläger F, Loretz B, Murgia X, Lehr CM.

Biomacromolecules. 2018 Aug 13;19(8):3489-3501. doi: 10.1021/acs.biomac.8b00795. Epub 2018 Jul 23.

PMID:
29989799
20.

Human airway mucus alters susceptibility of Pseudomonas aeruginosa biofilms to tobramycin, but not colistin.

Müller L, Murgia X, Siebenbürger L, Börger C, Schwarzkopf K, Sewald K, Häussler S, Braun A, Lehr CM, Hittinger M, Wronski S.

J Antimicrob Chemother. 2018 Oct 1;73(10):2762-2769. doi: 10.1093/jac/dky241.

PMID:
29982453

Supplemental Content

Loading ...
Support Center